NTRB
NutribandBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
AVERSA remains a differentiated abuse-deterrent transdermal program with broad patent protection, and the March 2026 brand-name/labeling work shows the company is still pushing the regulatory package forward; the company also continues to frame the lead patch as potentially first-in-class with peak annual U.S. sales potential of $80 million to $200 million [#8-K-2026-04-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
FDA approval and clinical development are still unresolved for AVERSA Fentanyl.
Momentum
79
Value
41
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.10 · Bull $8.00 · Bear $1.40
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $15.00
Why
Momentum79 · Δ7d -
Value41 · Δ7d +0.0
Sentiment60 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
79
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
60
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 78.7 / Value 41.1 / Sentiment 59.9
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$37.44M
Beta
1.87
Shares Out
12.16M
P/E (TTM) · Derived
-1.2
P/S (TTM)
23.94
P/FCF (TTM) · Derived
-8.35
Rev YoY
-35.1%
EPS YoY
-18.1%
Gross Margin
+26.2%
Op Margin
-564.3%
Net Debt
-$4.33M
Current Ratio
5.26
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology